Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018;91(2):147-150.
doi: 10.15386/cjmed-993. Epub 2018 Apr 25.

Non-alcoholic fatty liver disease: an update on diagnosis

Dan L Dumitrascu  1 , Manuela G Neuman  2   3
Affiliations
Review

Non-alcoholic fatty liver disease: an update on diagnosis

Dan L Dumitrascu et al. Clujul Med. 2018.

Abstract

Background and aim: The non-alcoholic fatty liver disease (NAFLD) and its sub-entity, the non-alcoholic steatohepatitis (NASH) represent a field of a tremendous progress in recent years. Clinicians need to remain updated with new data on pathogenesis and therapy. The present mini review aims to present some new scientific reports on the diagnosis of NAFLD and NASH for clinical practitioners.

Methods: A systematic literature search of the main international databases was performed. We looked for seminal and innovative papers published in main international languages. A narrative review of the topic was consequently written.

Results: This review describes new data on the diagnosis of NAFLD including NASH. Liver punction biopsy remains the gold standard. However many patients and clinicians prefer to use noninvasive methods. We present the serological tests and the imaging methods used to diagnose inflammation and fibrosis occurring in NAFLD and NASH.

Conclusions: NAFLD-NASH are multifaceted entities that have to be diagnosed and treated by skilled and informed practitioners.

Keywords: fibrosis; imaging; laboratory markers; non-alcoholic fatty liver; nonalcoholic steatohepatitis.

PubMed Disclaimer

References

    1. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55:2005–2023. - PubMed
    1. Neuman MG, Voiculescu M, Nanau R, Maor Y, Melzer E, Cohen LB, et al. Non-alcoholic steatohepatitis: Clinical and translational research. J Pharm Pharm Sci. 2016;19(1):8–24. - PubMed
    1. Tannapfel A, Denk H, Dienes HP, Langner C, Schirmacher P, Trauner M, et al. Histopathological diagnosis ofnon-alcoholic and alcoholic fatty liver disease. Virchows Arch. 2011;458:511–523. - PubMed
    1. Neuman MG, French SW, French BA, Seitz HK, Cohen LB, Mueller S, et al. Alcoholic and non-alcoholic steatohepatitis. Exp Mol Pathol. 2014;97:492–510. - PMC - PubMed
    1. Adler M, Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients. Am J Med. 1979;67:811–816. - PubMed

LinkOut - more resources